Price $215.00 |
Market Cap
7.32B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
45.7
|
P/B
11.22
|
P/S
10.48
|
Dividend %
-
|
|
P/CF
159.4
|
P/FCF
46.5
|
Op. Cash Flow
181.2K
|
FCF
3.5
|
|
Op. Margin
29.20%
|
Net Margin
23.60%
|
ROE
26.80%
|
ROI
15.20%
|
|
ROA
16.60%
|
EPS Growth
109.90%
|
Current Ratio
1.8
|
Debt/Equity
0.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.90 | - | - | 13.5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $23.52 | - | 0.10% | 1.1B | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.62 | - | - | 38.6M | Strong Buy |
| Aerpio Pharmaceuticals Inc (ARPO) | $1.49 | - | - | 58.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
